Treatment of High-flow Priapism with Superselective Transcatheter Embolization in 27 Patients

A Multicenter Study

Kyung Rae Kim, Ji Hoon Shin, Ho Young Song, Gi Young Ko, Hyun Ki Yoon, Kyu Bo Sung, Tae Young Ahn, Chang Won Kim, Young Hwan Kim, Heung Kyu Ko, Byung Kook Kwak, Hyung Jin Shim, Hwan Hoon Chung, Sung Wook Shin, Jae Ik Bae

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Purpose: To evaluate the effectiveness and safety of treatment of high-flow priapism (HFP) with superselective transcatheter embolization at nine university hospitals. Materials and Methods: Between May 1994 and October 2006, 27 patients underwent superselective embolization of the cavernous artery for HFP. Trauma was apparent in 22 patients, there was self-administered intracavernosal injection for erectile dysfunction in two, and the remaining three did not recall any penile or perineal trauma. The embolic agents used were autologous blood clot (n = 12), gelatin sponge (n = 12), microcoils combined with gelatin sponge (n = 1), polyvinyl alcohol (n = 1), and N-butyl cyanoacrylate (n = 1). Recurrence of priapism and change in erectile function were evaluated during a mean follow-up of 13 months. Differences in results between patients treated with autologous blood clot versus gelatin sponge were statistically analyzed with use of the χ2 test. Results: In 24 of 27 patients (89%), a single embolization was sufficient for complete resolution of priapism. Repeat embolization was required in two patients (7%), and in the remaining patient (4%), shunt surgery was performed after embolization as a result of HFP coexisting with corporeal venoocclusive dysfunction. Eighteen of 23 patients (78%) who had premorbid normal erectile function showed maintained potency during the follow-up period. There was no significant difference affecting required repeat embolization (P = .537) and change in quality of erection (P = .615) during the follow-up period between the autologous blood clot and gelatin sponge treatment groups. Conclusions: Superselective transcatheter embolization in the treatment of HFP is effective and ensures a high level of preservation of premorbid erectile function.

Original languageEnglish
Pages (from-to)1222-1226
Number of pages5
JournalJournal of Vascular and Interventional Radiology
Volume18
Issue number10
DOIs
Publication statusPublished - 2007 Oct 1

Fingerprint

Priapism
Multicenter Studies
Porifera
Gelatin
Thrombosis
Therapeutics
Enbucrilate
Polyvinyl Alcohol
Wounds and Injuries
Erectile Dysfunction
Arteries
Safety
Recurrence
Injections

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Cardiology and Cardiovascular Medicine

Cite this

Treatment of High-flow Priapism with Superselective Transcatheter Embolization in 27 Patients : A Multicenter Study. / Kim, Kyung Rae; Shin, Ji Hoon; Song, Ho Young; Ko, Gi Young; Yoon, Hyun Ki; Sung, Kyu Bo; Ahn, Tae Young; Kim, Chang Won; Kim, Young Hwan; Ko, Heung Kyu; Kwak, Byung Kook; Shim, Hyung Jin; Chung, Hwan Hoon; Shin, Sung Wook; Bae, Jae Ik.

In: Journal of Vascular and Interventional Radiology, Vol. 18, No. 10, 01.10.2007, p. 1222-1226.

Research output: Contribution to journalArticle

Kim, KR, Shin, JH, Song, HY, Ko, GY, Yoon, HK, Sung, KB, Ahn, TY, Kim, CW, Kim, YH, Ko, HK, Kwak, BK, Shim, HJ, Chung, HH, Shin, SW & Bae, JI 2007, 'Treatment of High-flow Priapism with Superselective Transcatheter Embolization in 27 Patients: A Multicenter Study', Journal of Vascular and Interventional Radiology, vol. 18, no. 10, pp. 1222-1226. https://doi.org/10.1016/j.jvir.2007.06.030
Kim, Kyung Rae ; Shin, Ji Hoon ; Song, Ho Young ; Ko, Gi Young ; Yoon, Hyun Ki ; Sung, Kyu Bo ; Ahn, Tae Young ; Kim, Chang Won ; Kim, Young Hwan ; Ko, Heung Kyu ; Kwak, Byung Kook ; Shim, Hyung Jin ; Chung, Hwan Hoon ; Shin, Sung Wook ; Bae, Jae Ik. / Treatment of High-flow Priapism with Superselective Transcatheter Embolization in 27 Patients : A Multicenter Study. In: Journal of Vascular and Interventional Radiology. 2007 ; Vol. 18, No. 10. pp. 1222-1226.
@article{dae3c4b7278e41a29805f18f974707a5,
title = "Treatment of High-flow Priapism with Superselective Transcatheter Embolization in 27 Patients: A Multicenter Study",
abstract = "Purpose: To evaluate the effectiveness and safety of treatment of high-flow priapism (HFP) with superselective transcatheter embolization at nine university hospitals. Materials and Methods: Between May 1994 and October 2006, 27 patients underwent superselective embolization of the cavernous artery for HFP. Trauma was apparent in 22 patients, there was self-administered intracavernosal injection for erectile dysfunction in two, and the remaining three did not recall any penile or perineal trauma. The embolic agents used were autologous blood clot (n = 12), gelatin sponge (n = 12), microcoils combined with gelatin sponge (n = 1), polyvinyl alcohol (n = 1), and N-butyl cyanoacrylate (n = 1). Recurrence of priapism and change in erectile function were evaluated during a mean follow-up of 13 months. Differences in results between patients treated with autologous blood clot versus gelatin sponge were statistically analyzed with use of the χ2 test. Results: In 24 of 27 patients (89{\%}), a single embolization was sufficient for complete resolution of priapism. Repeat embolization was required in two patients (7{\%}), and in the remaining patient (4{\%}), shunt surgery was performed after embolization as a result of HFP coexisting with corporeal venoocclusive dysfunction. Eighteen of 23 patients (78{\%}) who had premorbid normal erectile function showed maintained potency during the follow-up period. There was no significant difference affecting required repeat embolization (P = .537) and change in quality of erection (P = .615) during the follow-up period between the autologous blood clot and gelatin sponge treatment groups. Conclusions: Superselective transcatheter embolization in the treatment of HFP is effective and ensures a high level of preservation of premorbid erectile function.",
author = "Kim, {Kyung Rae} and Shin, {Ji Hoon} and Song, {Ho Young} and Ko, {Gi Young} and Yoon, {Hyun Ki} and Sung, {Kyu Bo} and Ahn, {Tae Young} and Kim, {Chang Won} and Kim, {Young Hwan} and Ko, {Heung Kyu} and Kwak, {Byung Kook} and Shim, {Hyung Jin} and Chung, {Hwan Hoon} and Shin, {Sung Wook} and Bae, {Jae Ik}",
year = "2007",
month = "10",
day = "1",
doi = "10.1016/j.jvir.2007.06.030",
language = "English",
volume = "18",
pages = "1222--1226",
journal = "Journal of Vascular and Interventional Radiology",
issn = "1051-0443",
publisher = "Elsevier Inc.",
number = "10",

}

TY - JOUR

T1 - Treatment of High-flow Priapism with Superselective Transcatheter Embolization in 27 Patients

T2 - A Multicenter Study

AU - Kim, Kyung Rae

AU - Shin, Ji Hoon

AU - Song, Ho Young

AU - Ko, Gi Young

AU - Yoon, Hyun Ki

AU - Sung, Kyu Bo

AU - Ahn, Tae Young

AU - Kim, Chang Won

AU - Kim, Young Hwan

AU - Ko, Heung Kyu

AU - Kwak, Byung Kook

AU - Shim, Hyung Jin

AU - Chung, Hwan Hoon

AU - Shin, Sung Wook

AU - Bae, Jae Ik

PY - 2007/10/1

Y1 - 2007/10/1

N2 - Purpose: To evaluate the effectiveness and safety of treatment of high-flow priapism (HFP) with superselective transcatheter embolization at nine university hospitals. Materials and Methods: Between May 1994 and October 2006, 27 patients underwent superselective embolization of the cavernous artery for HFP. Trauma was apparent in 22 patients, there was self-administered intracavernosal injection for erectile dysfunction in two, and the remaining three did not recall any penile or perineal trauma. The embolic agents used were autologous blood clot (n = 12), gelatin sponge (n = 12), microcoils combined with gelatin sponge (n = 1), polyvinyl alcohol (n = 1), and N-butyl cyanoacrylate (n = 1). Recurrence of priapism and change in erectile function were evaluated during a mean follow-up of 13 months. Differences in results between patients treated with autologous blood clot versus gelatin sponge were statistically analyzed with use of the χ2 test. Results: In 24 of 27 patients (89%), a single embolization was sufficient for complete resolution of priapism. Repeat embolization was required in two patients (7%), and in the remaining patient (4%), shunt surgery was performed after embolization as a result of HFP coexisting with corporeal venoocclusive dysfunction. Eighteen of 23 patients (78%) who had premorbid normal erectile function showed maintained potency during the follow-up period. There was no significant difference affecting required repeat embolization (P = .537) and change in quality of erection (P = .615) during the follow-up period between the autologous blood clot and gelatin sponge treatment groups. Conclusions: Superselective transcatheter embolization in the treatment of HFP is effective and ensures a high level of preservation of premorbid erectile function.

AB - Purpose: To evaluate the effectiveness and safety of treatment of high-flow priapism (HFP) with superselective transcatheter embolization at nine university hospitals. Materials and Methods: Between May 1994 and October 2006, 27 patients underwent superselective embolization of the cavernous artery for HFP. Trauma was apparent in 22 patients, there was self-administered intracavernosal injection for erectile dysfunction in two, and the remaining three did not recall any penile or perineal trauma. The embolic agents used were autologous blood clot (n = 12), gelatin sponge (n = 12), microcoils combined with gelatin sponge (n = 1), polyvinyl alcohol (n = 1), and N-butyl cyanoacrylate (n = 1). Recurrence of priapism and change in erectile function were evaluated during a mean follow-up of 13 months. Differences in results between patients treated with autologous blood clot versus gelatin sponge were statistically analyzed with use of the χ2 test. Results: In 24 of 27 patients (89%), a single embolization was sufficient for complete resolution of priapism. Repeat embolization was required in two patients (7%), and in the remaining patient (4%), shunt surgery was performed after embolization as a result of HFP coexisting with corporeal venoocclusive dysfunction. Eighteen of 23 patients (78%) who had premorbid normal erectile function showed maintained potency during the follow-up period. There was no significant difference affecting required repeat embolization (P = .537) and change in quality of erection (P = .615) during the follow-up period between the autologous blood clot and gelatin sponge treatment groups. Conclusions: Superselective transcatheter embolization in the treatment of HFP is effective and ensures a high level of preservation of premorbid erectile function.

UR - http://www.scopus.com/inward/record.url?scp=34548853715&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34548853715&partnerID=8YFLogxK

U2 - 10.1016/j.jvir.2007.06.030

DO - 10.1016/j.jvir.2007.06.030

M3 - Article

VL - 18

SP - 1222

EP - 1226

JO - Journal of Vascular and Interventional Radiology

JF - Journal of Vascular and Interventional Radiology

SN - 1051-0443

IS - 10

ER -